Prostate cancer mortality in northern Sweden, with special reference to tumor grade and patient age

Urology

Volumn 49, Issue 3, 1997, Pages 374-378

  Grönberg, Henrik ^a   Damber, Lena ^a   Jonson, Håkan ^a   Damber, Jan Erik ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER REGISTRY; CANCER STATISTICS; CANCER SURVIVAL; CAUSE OF DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SWEDEN;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; SURVIVAL RATE; SWEDEN;

EID: 0342601450     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00508-0     Document Type: Article

References (15)

1. Chodak GW, Thisted RA, Gerber GS, Johansson JE, Adolfsson J, Jones GW, Chisholm GD, Moskovitz B, Livne PM, and Warner J: Results of conservative management of clinically localized prostate cancer. N Engl J Med 330: 242-248, 1994.
2. Swansson GP, Cupps RE, Utz DC, Ilstrup DM, Zincke H, and Myers RP: Definite therapy for prostate carcinoma: Mayo Clinic results at 15 years after treatment. Br J Radiol 67: 877-889, 1994.
3. Aus G, Hugosson J, and Norlen L: Long-term survival and mortality in prostate cancer treated with noncurative intent. J Urol 154: 460-465, 1995.
4. Johansson JE, Adami HO, Andersson SO, Bergström R, Holmberg L, and Krusemo UB: High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA 267: 2191-2196, 1992.
5. Adolfsson J, Carstensen J, and Löwhagen T: Deferred treatment in clinically localised prostatic carcinoma. Br J Urol 69: 183-187, 1992.
6. Albertsen PC, Fryback DG, Storer BE, Kolon TF, and Fine J: Long-term survival among men with conservatively treated localized prostate cancer. JAMA 274: 626-631, 1995.
7. Grönberg H, Bergh A, Damber JE, Jonsson H, Lenner P, and Ångström T: Prostate cancer in northern Sweden. Incidence, survival and mortality in relation to tumour grade. Acta Oncol 33: 359-363, 1994.
8. Hakulinen T, and Abeywickrama KH: A computer program package for relative survival analysis. Comput Programs Biomed 19: 197-207, 1985.
9. Causes of Death 1991 in Sweden. Official Statistics of Sweden. Stockholm, Sweden, National Central Bureau of Statistics, 1993.
10. Grönberg H, Damber JE, Jonsson H, and Lenner P: Patient age as a prognostic factor in prostate cancer. J Urol 152: 892-895, 1994.
11. Johansson JE, and Holmberg L: 15-year survival in a cohort of prostate cancer patients. Scand J Urol Nephrol Suppl 29: 26, 1995.
12. Goodman CM, Ritchie AWS, and Chisholm GD: Measures of mortality in prostatic cancer. Br J Cancer 61: 465-468, 1990.
13. Hugosson J, Aus G, Bergdahl C, and Bergdahl S: Prostate cancer mortality in patients surviving more than 10 years after diagnosis. J Urol 154: 2115-2117, 1995.
14. Abrahamsson PA, Adami HO, Taube A, Kim K, Zelen M, and Kulldorff M: Long-time survival and mortality in prostate cancer treated with noncurative intent (letter). J Urol 155: 296-298, 1996.
15. Chodak GW: Editorial: what to expect from prostate cancer. J Urol 154: 2132-2133, 1995.